Tohru Murayama

2.5k total citations
76 papers, 1.1k citations indexed

About

Tohru Murayama is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Tohru Murayama has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 20 papers in Genetics and 16 papers in Oncology. Recurrent topics in Tohru Murayama's work include Acute Myeloid Leukemia Research (17 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Tohru Murayama is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Hematopoietic Stem Cell Transplantation (15 papers). Tohru Murayama collaborates with scholars based in Japan and United States. Tohru Murayama's co-authors include Toshimitsu Matsui, Mitsuhiro Ito, Kazuo Chihara, Tohru Taniguchi, Tamio Koizumi, Shion Imoto, Ryuichiro Nishimura, Toshitaro Nakagawa, Takashi Isobe and Tatsuo Tsukamoto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Tohru Murayama

71 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tohru Murayama Japan 19 355 295 266 180 172 76 1.1k
Miguel Aguilar‐Santelises Sweden 17 575 1.6× 147 0.5× 203 0.8× 178 1.0× 328 1.9× 41 1.3k
Cecilia Garabaya Spain 13 927 2.6× 408 1.4× 308 1.2× 93 0.5× 348 2.0× 14 1.8k
Donald P. Lombardi United States 16 643 1.8× 142 0.5× 298 1.1× 50 0.3× 100 0.6× 26 1.4k
Shoshana Merchav Israel 20 337 0.9× 451 1.5× 221 0.8× 51 0.3× 133 0.8× 37 1.1k
Roberta Giuliani Italy 16 590 1.7× 361 1.2× 185 0.7× 27 0.1× 114 0.7× 25 1.1k
Liming Bao United States 23 503 1.4× 188 0.6× 193 0.7× 155 0.9× 89 0.5× 71 1.3k
Annalisa Camporeale Italy 21 617 1.7× 98 0.3× 389 1.5× 176 1.0× 165 1.0× 28 1.4k
L. Beckman Sweden 17 443 1.2× 173 0.6× 253 1.0× 51 0.3× 145 0.8× 61 1.0k
Youqi Han Canada 12 776 2.2× 153 0.5× 196 0.7× 36 0.2× 36 0.2× 16 1.4k

Countries citing papers authored by Tohru Murayama

Since Specialization
Citations

This map shows the geographic impact of Tohru Murayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tohru Murayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tohru Murayama more than expected).

Fields of papers citing papers by Tohru Murayama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tohru Murayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tohru Murayama. The network helps show where Tohru Murayama may publish in the future.

Co-authorship network of co-authors of Tohru Murayama

This figure shows the co-authorship network connecting the top 25 collaborators of Tohru Murayama. A scholar is included among the top collaborators of Tohru Murayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tohru Murayama. Tohru Murayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yakushijin, Kimikazu, Keiji Kurata, Takahiro Tsuji, et al.. (2024). Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease. Bone Marrow Transplantation. 59(4). 518–525. 1 indexed citations
2.
Hayakawa, Fumihiko, Naoki Mori, Kiyotoshi Imai, et al.. (2024). Nelarabine‐combined chemotherapy improves outcome of T‐cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T‐ALL213‐O. Cancer Science. 116(2). 453–461. 1 indexed citations
3.
Yakushijin, Kimikazu, Shigeki Nagao, Keiji Kurata, et al.. (2023). Early diagnosis of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation, with modified diagnostic criteria including refractory thrombocytopenia. SHILAP Revista de lepidopterología. 4(3). 695–704. 2 indexed citations
4.
Saito, Takeshi, Yoshihiro Hatta, Fumihiko Hayakawa, et al.. (2020). Combination of clofarabine, etoposide, and cyclophosphamide in adult relapsed/refractory acute lymphoblastic leukemia: a phase 1/2 dose-escalation study by the Japan Adult Leukemia Study Group. International Journal of Hematology. 113(3). 395–403. 3 indexed citations
5.
6.
Inui, Yumiko, Hiroshi Matsuoka, Kimikazu Yakushijin, et al.. (2015). Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal. Leukemia & lymphoma. 56(11). 3045–3051. 71 indexed citations
7.
Katagiri, Takamasa, Keisuke Kataoka, Akio Maeda, et al.. (2015). A Cure for Paroxysmal Nocturnal Hemoglobinuria Using Molecular Targeted Therapy Specific to a Driver Mutation. Blood. 126(23). 1215–1215. 3 indexed citations
8.
Sakura, Toru, Fumihiko Hayakawa, Isamu Sugiura, et al.. (2015). Effectiveness of High-Dose MTX Therapy for Adult Ph-Negative ALL By Randomized Trial: JALSG ALL202-O. Blood. 126(23). 79–79. 1 indexed citations
9.
Gomyo, Hiroshi, Kazuyoshi Kajimoto, Akio Maeda, et al.. (2010). CD56-positive diffuse large B-cell lymphoma: possible association with extranodal involvement and bcl-6 expression. Hematology. 15(3). 157–161. 7 indexed citations
10.
Murayama, Tohru, et al.. (2007). Effect of Forcing Culture Conditions on Content of Antioxidative Component in Eleutherococcus sciadophylloides (Franch. & Savat.) H. Ohashi. Horticultural Research (Japan). 6(2). 241–245. 1 indexed citations
11.
12.
13.
Murayama, Tohru, Hiroshi Yada, Masuko Kobori, Hiroshi Shinmoto, & Tojiro Tsushida. (2002). Evaluation of three antioxidants and their identification and radical scavenging activities in edible chrysanthemums [Dendranthema]. 1 indexed citations
14.
Sugimoto, Tohru, Shion Imoto, Yoshinobu Matsuo, et al.. (2001). T-cell receptor γδ T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype. Annals of Hematology. 80(12). 749–751. 20 indexed citations
15.
Yakushijin, Kimikazu, Tohru Murayama, Ishikazu Mizuno, et al.. (2001). Chronic eosinophilic leukemia with unique chromosomal abnormality, t(5;12) (q33;q22). American Journal of Hematology. 68(4). 301–301.
16.
Imoto, Shion, Tohru Murayama, Hiroshi Gomyo, et al.. (2000). Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 26(7). 809–810. 7 indexed citations
17.
Imoto, Shion, Makoto Hashimoto, Tohru Murayama, et al.. (1999). Response to Granulocyte Colony-Stimulating Factor in an Autoimmune Neutropenic Adult. Acta Haematologica. 101(3). 153–156. 7 indexed citations
18.
Murayama, Tohru, Tamio Koizumi, Hiranmoy Das, et al.. (1999). Soluble fas ligand in natural killer cell lymphoma. American Journal of Hematology. 62(4). 253–255. 11 indexed citations
19.
Murayama, Tohru, et al.. (1992). Mesenteric fibromatosis presenting as fever of unknown origin.. PubMed. 87(10). 1503–5. 10 indexed citations
20.
Horie, Toshiharu, et al.. (1989). Protection of Liver Microsomal Membranes from Lipid Peroxidation by Garlic Extract. Planta Medica. 55(6). 506–508. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Aguilar‐Santelises Breakdown of academic impact, for papers by Cecilia Garabaya Breakdown of academic impact, for papers by Donald P. Lombardi Breakdown of academic impact, for papers by Shoshana Merchav Breakdown of academic impact, for papers by Roberta Giuliani Breakdown of academic impact, for papers by Liming Bao Breakdown of academic impact, for papers by Annalisa Camporeale Breakdown of academic impact, for papers by L. Beckman Breakdown of academic impact, for papers by Youqi Han
Rankless by CCL
2026